当前位置:
X-MOL 学术
›
Nat. Biotechnol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
COVID-19 antibodies on trial
Nature Biotechnology ( IF 46.9 ) Pub Date : 2020-10-21 , DOI: 10.1038/s41587-020-0732-8 Laura DeFrancesco 1
Nature Biotechnology ( IF 46.9 ) Pub Date : 2020-10-21 , DOI: 10.1038/s41587-020-0732-8 Laura DeFrancesco 1
Affiliation
With the first readouts of trials of antibodies against COVID-19 appearing and others coming thick and fast, Nature Biotechnology asked a group of experts to comment on the challenges and timelines for these products.
中文翻译:
COVID-19 抗体正在试验中
随着针对 COVID-19 的抗体试验的首次公布以及其他试验的陆续公布,《Nature Biotechnology》请一组专家对这些产品的挑战和时间表发表评论。
更新日期:2020-10-28
中文翻译:
COVID-19 抗体正在试验中
随着针对 COVID-19 的抗体试验的首次公布以及其他试验的陆续公布,《Nature Biotechnology》请一组专家对这些产品的挑战和时间表发表评论。